These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 9183148)

  • 21. Cross-sectional analysis of abnormalities of mineral homeostasis, vitamin D and parathyroid hormone in a cohort of pre-dialysis patients. The chronic renal impairment in Birmingham (CRIB) study.
    Zehnder D; Landray MJ; Wheeler DC; Fraser W; Blackwell L; Nuttall S; Hughes SV; Townend J; Ferro C; Baigent C; Hewison M
    Nephron Clin Pract; 2007; 107(3):c109-16. PubMed ID: 17890873
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Direct evidence for a causative role of FGF23 in the abnormal renal phosphate handling and vitamin D metabolism in rats with early-stage chronic kidney disease.
    Hasegawa H; Nagano N; Urakawa I; Yamazaki Y; Iijima K; Fujita T; Yamashita T; Fukumoto S; Shimada T
    Kidney Int; 2010 Nov; 78(10):975-80. PubMed ID: 20844473
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of hypophosphatemia in calcium nephrolithiasis.
    Yamakawa K; Kawamura J
    Mol Urol; 2000; 4(4):365-70. PubMed ID: 11156704
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Strategies to minimize bone disease in renal failure.
    Martin KJ; González EA
    Am J Kidney Dis; 2001 Dec; 38(6):1430-6. PubMed ID: 11728986
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A case of hypercalcemia Indications for 1,25-dihydroxyvitamin D prescription.
    Malandain D; Roussey G; Leloupp AG; Graveline N; Masson D; Bach-Ngohou K
    Ann Biol Clin (Paris); 2015; 73(5):573-80. PubMed ID: 26489816
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and metabolic clearance of 1,25-dihydroxyvitamin D as determinants of serum concentrations: a comparison of two methods.
    Maierhofer WJ; Gray RW; Adams ND; Smith GA; Lemann J
    J Clin Endocrinol Metab; 1981 Sep; 53(3):472-5. PubMed ID: 6897931
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma 1,25-Dihydroxyvitamin D and the Risk of Developing Hypertension: The Prevention of Renal and Vascular End-Stage Disease Study.
    van Ballegooijen AJ; Gansevoort RT; Lambers-Heerspink HJ; de Zeeuw D; Visser M; Brouwer IA; Kema IP; de Borst MH; Bakker SJ; Joosten MM
    Hypertension; 2015 Sep; 66(3):563-70. PubMed ID: 26195480
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Intact whole bioactive parathormone: problems arising from comparing different methods].
    Marangella M; Migliardi M; Dutto F; Mengozzi G; Marranca D; Bagnis C; Berutti S; Gallone G; Aimo G; Ramello A; Fonzo D
    G Ital Nefrol; 2002; 19(4):467-75. PubMed ID: 12369051
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Performance and clinical utility of a commercially available 'C-terminal' PTH assay.
    Ingle AR; Bailey JE; Matthews HL; Harrop JS
    Ann Clin Biochem; 1986 Jul; 23 ( Pt 4)():434-9. PubMed ID: 3767272
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fibroblast growth factor-23 is regulated by 1alpha,25-dihydroxyvitamin D.
    Collins MT; Lindsay JR; Jain A; Kelly MH; Cutler CM; Weinstein LS; Liu J; Fedarko NS; Winer KK
    J Bone Miner Res; 2005 Nov; 20(11):1944-50. PubMed ID: 16234967
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of calcium and 1,25 dihydroxyvitamin D on the level of parathyroid hormone in patients with secondary hyperparathyroidism due to chronic renal insufficiency.
    Vucković S; Paunković N
    Med Pregl; 1993; 46 Suppl 1():40-2. PubMed ID: 8569602
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Parathyroid function in sarcoidosis.
    Cushard WG; Simon AB; Canterbury JM; Reiss E
    N Engl J Med; 1972 Feb; 286(8):395-8. PubMed ID: 5009230
    [No Abstract]   [Full Text] [Related]  

  • 33. Measurement of human serum parathyroid hormone in disorders of calcium metabolism and during administration of certain gut hormones.
    Coetzee J; Klaff LJ; Epstein S
    S Afr Med J; 1980 Feb; 57(5):165-70. PubMed ID: 7404129
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vitamin D analogs as therapeutic agents: a clinical study update.
    Wu-Wong JR; Tian J; Goltzman D
    Curr Opin Investig Drugs; 2004 Mar; 5(3):320-6. PubMed ID: 15083599
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vitamin D: its role in cancer prevention and treatment.
    Holick MF
    Prog Biophys Mol Biol; 2006 Sep; 92(1):49-59. PubMed ID: 16566961
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of 1 alpha, 25-dihydroxyvitamin D in the mediation of intestinal hyperabsorption of calcium in primary hyperparathyroidism and absorptive hypercalciuria.
    Kaplan RA; Haussler MR; Deftos LJ; Bone H; Pak CY
    J Clin Invest; 1977 May; 59(5):756-60. PubMed ID: 192763
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The importance of circulating 1,25-dihydroxyvitamin D in the pathogenesis of hypercalciuria and renal-stone formation in primary hyperparathyroidism.
    Broadus AE; Horst RL; Lang R; Littledike ET; Rasmussen H
    N Engl J Med; 1980 Feb; 302(8):421-6. PubMed ID: 7351950
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Elevated 1, 25-dihydroxyvitamin D levels are associated with protracted treatment in sarcoidosis.
    Kavathia D; Buckley JD; Rao D; Rybicki B; Burke R
    Respir Med; 2010 Apr; 104(4):564-70. PubMed ID: 20071158
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum 1,25-Dihydroxyvitamin D Level Is Inappropriate for Use in Prospective Studies of Cancer Incidence.
    Grant WB
    Circ J; 2018 Jul; 82(8):2215. PubMed ID: 29998919
    [No Abstract]   [Full Text] [Related]  

  • 40. Serum 1,25-Dihydroxyvitamin D Level Is Inappropriate for Use in Prospective Studies of Cancer Incidence　- Reply.
    Umehara K; Mukai N; Kitazono T; Hoka S; Kiyohara Y; Ninomiya T
    Circ J; 2018 Jul; 82(8):2216. PubMed ID: 29998920
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.